| Quarter (USD) | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Dec 20 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 220.39 mm | 220.39 mm | 220.39 mm | |||
| Cash burn (monthly) | 4.14 mm | 3.74 mm | 3.74 mm | |||
| Cash used (since last report) | 203.07 mm | 183.40 mm | 183.18 mm | |||
| Cash remaining | 17.32 mm | 36.99 mm | 37.22 mm | |||
| Runway (months of cash) | 4.2 | 9.9 | 10.0 | |||
| 13F holders | Current |
|---|---|
| Total holders | 6 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 494.35 mm |
| Total shares | 24.07 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| MRK Merck & Co. | 11.78 mm | $301.84 mm |
| Polaris Partners VIII | 3.20 mm | $47.54 mm |
| Versant Venture Capital VI | 3.18 mm | $57.15 mm |
| Roche Finance | 3.09 mm | $45.83 mm |
| Access Industries | 2.83 mm | $41.99 mm |
| AI Pan | 12.00 | $0.00 |
